BOYA BIOLOGY
30029415.620.39% ( +0.06 )
BOYA BIOLOGY (300294)
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood pro...
- Open
- 15.42
- High
- 15.67
- Low
- 15.33
- Prev. Close
- 15.56
- Volume
- 57.22K
- Turnover
- 88.78M
- Avg Price
- 15.52
- Bid/Ask Ratio
- --
- Amplitude
- 2.19%
- 52wk High
- 27.77
- Volume Ratio
- 0.58
- Turnover Ratio
- 1.13%
BOYA BIOLOGY Analyst Rating
View MoreForecast & Rating
May 17, 2026Price forecast
¥28.0079.26%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy25.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- 同壁财经 · May 30 at 10:02 AM
BOYA BIOLOGY has continuously received a Wind ESG A rating, with a comprehensive score of 7.16
- AASTOCKS · Mar 22 at 12:04 AM
China Resources Pharma's subsidiary China Resources Boya Biology earned 113 million RMB for the year, a decline of 71.6%
- AASTOCKS · Feb 24 at 10:29 PM
China Resources Pharma's recombinant coagulation factor IX has received the clinical trial approval notice for drugs in mainland China
- AASTOCKS · Feb 1 at 03:51 AM
CHINARES PHARMA subsidiary BOYA BIOLOGY expects a significant decrease in annual net profit due to impairment reduction
- AASTOCKS · Oct 27, 2025 at 09:16 AM
China Resources Pharmaceutical's subsidiary BOYA BIOLOGY earned 343 million RMB in the first nine months, a decline of 16.8%
- Zhitong · Sep 9, 2025 at 03:58 AM
BOYA BIOLOGY: Completed the transfer of 80% equity in Jiangxi Boya Xinhao Pharmaceutical Co., Ltd
